Company Filing History:

15 out of 92

Harbor Branch Oceanographic Institution, Inc.

patents

2 out of 215

Kirin Beer Kabushiki Kaisha

Instituto Biomar, S.a.

patents

Years Active: 1987-2005

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6864283 - Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity (2005-03-08),

2. 6391900 - Cytotoxic tris(oxazole)-containing macrolides (2002-05-21),

3. 5936076 - .alpha.galactosylceramide derivatives (1999-08-10),

4. 5780441 - Sphingoglycolipid compounds and therapeutic uses thereof (1998-07-14),

5. 5449684 - Cytotoxic compounds (1995-09-12),

6. 4942180 - Antitumor chamigrene derivatives and their methods of use (1990-07-17),

7. 4921873 - Antiviral and antitumor cyclohexadienone compositions (1990-05-01),

8. 4902716 - Anti-viral chamigrene derivatives (1990-02-20),

9. 4895854 - Antitumor alkaloids (1990-01-23),

10. 4895853 - Antitumor alkaloids (1990-01-23),

11. 4895852 - Antitumor alkaloids (1990-01-23),

12. 4882445 - Antitumor cyclohexanone compositions and derivatives thereof (1989-11-21),

13. 4859782 - Misakinolide compositions and their derivatives (1989-08-22),

14. 4851441 - Antiviral guanidine derivatives compositions and their methods of use (1989-07-25),

15. 4808590 - Antiviral, antitumor and antifungal compositions and their methods of use (1989-02-28),

Title: The Innovative Contributions of Tatsuo Higa

Introduction: Tatsuo Higa, an accomplished inventor based in Okinawa, Japan, has made significant strides in the field of pharmaceutical innovations. With a notable portfolio comprising 20 patents, his work focuses primarily on antitumor compounds that have the potential to revolutionize cancer treatment.

Latest Patents: One of Higa's latest patents is for oxy- and amino-substituted tetrahydrofuryl derivatives with antitumor activity. This patent features a complex formula that includes a variety of chemical groups designed to enhance the efficacy of these compounds in targeting cancer cells. The patent outlines various compounds where R and R' can be selected from different groups including substituted or unsubstituted aliphatic and aromatic units, offering a diverse toolkit for future drug development.

Career Highlights: Higa has had an impressive career, making substantial contributions to the field of medicinal chemistry. He has worked with notable institutions such as Harbor Branch Oceanographic Institution, Inc. and Kirin Beer Kabushiki Kaisha, gaining valuable experience that informs his inventive processes. His extensive research and development efforts have culminated in a robust number of patents that underscore his reputation as a leading inventor.

Collaborations: Throughout his career, Tatsuo Higa has collaborated with esteemed colleagues, including Ryuichi Sakai and Shinichi Sakemi. These collaborations have undoubtedly played a role in enhancing his innovative capabilities and expanding the applications of his research findings.

Conclusion: Tatsuo Higa stands out as a prominent inventor whose work continues to push the boundaries of pharmaceutical advancements. His dedication to developing antitumor compounds not only reflects his ingenuity but also contributes significantly to the ongoing fight against cancer. The breadth of his patents illustrates the profound impact of his work on medicine, and his collaborations underscore the importance of teamwork in fostering innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.